A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-03) →
What happened
Adbiotech updated the terms of convertible bonds to raise US$6.76M, about 15.8% of its market value.
For context, this raise equals about 15.8% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$6.76M |
| vs. market value | 15.8% |
| Filed | 2026-07-21, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260721001361 → open original filing |
Versions of this filing
- 2026-06-26Original
- 2026-07-21Amendment 1 (this page)
- 2026-08-13Amendment 2
- 2026-08-19Amendment 3
- 2026-08-21Amendment 4
- 2026-09-01Amendment 5
- 2026-09-03Amendment 6
Source: DART. Information only, not investment advice.